systematic_review
2012
High Quality
Huperzine A for mild cognitive impairment: a systematic review of randomised controlled trials
Yue J, Dong BR, Lin X, Yang M, Wu HM, Wu T
Published in Cochrane Database of Systematic Reviews
Methodology
Cochrane review searching for randomised controlled trials of huperzine A in mild cognitive impairment
Key Findings
No trials of adequate quality were identified, so no conclusion about efficacy in mild cognitive impairment could be drawn.
Conclusions
There is no reliable evidence that huperzine A benefits mild cognitive impairment.
Limitations
Absence of eligible trials.
Supplements Studied
Huperzine A
Compound
No trials of adequate quality were identified for mild cognitive impairment.
Related Health Concerns
Study Details
Year:2012
00Quality Score:8/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.